NATIONAL CHEMICAL LABORATORY
With the changing scenario in science, technology, and industry, this premier
organization is changing constantly to be current and contemporary.
Pune-based National Chemical Laxboratory (NCL), a constituent
laboratory of the Council of Scientific and Industrial Research (CSIR), started
five decades ago with the purpose to advance knowledge and to apply chemical
sciences for the good of people, is a vibrant organization. It is striving to
deliver outstanding performances in each sphere of its activities and live up to
the mission that it was entrusted with.
It has one of the best track records in the nation through
its contributions to the corpus of human knowledge in the area of chemistry and
allied disciplines. It has been committed to the development of processes,
materials, and products. It is second to none in terms of maintenance of
national resource centers of expertise, facilities, information and knowledge.
It has created and trained a cadre of highly skilled scientific workers. Its
influencing role in national and international scientific associations,
governmental bodies etc., is very lofty. For all this and more, it falls in the
category of "high output, high impact" institutions in the country
along with IISc, TIFR, AIIMS, IIT-B, IIT-K, IACS and Hyderabad University.
The laboratory over the years has forged strong industrial
and academic collaborations in pursuit of its objectives. It works closely with
many international companies and over 50 Indian companies. Some of the largest
companies, within and outside India, have benefited by such collaborations.
Examples include Reliance Industries, Indian Oil Corp., Oil and Natural Gas
Commission, and pharma majors like Ranbaxy, Cipla, and Cadila, and global
companies like GE, Dupont, Dow Chemicals and Unilever. It has close academic
links with several universities both Indian and foreign as well as with several
multilateral international R&D organizations.
Besides biotechnology, the core R&D areas of NCL include
catalysis, organic chemistry, polymer science and engineering, advanced
molecular materials, chemical and process engineering, scientific computing,
theory and molecular modeling. Strong biochemical science and engineering backed
by inputs from other diverse disciplines provided an extra dimension to NCL’s
biotechnology program.
Multidisciplinary biotech group
The biotechnology group at the laboratory is a
multidisciplinary and multi-skill R&D group with interest in the area of
biochemistry, molecular biology, microbiology, botany, and biochemical
engineering. It is supported by the state-of-the-art experimental facilities,
large-scale pilot plants for plant tissue culture, and scaled up facilities for
microbial processes and downstream separation.
The laboratory’s strong knowledge base has established its
competency in taking up projects in the areas like plant molecular biology and
agricultural biotechnology, plant tissue culture and microbiology, and enzyme
technology. In addition to taking up the projects, its process development and
design activity provides the vital link for translating a laboratory process to
a commercial plant. A team of chemists, technologists, and engineers work
together in achieving this task. The team members have acquired considerable
experience by implementing a number of projects of NCL and also participating
with industrial organizations and engineering companies on other projects. The
process technologies developed and implemented encompass a variety of areas like
catalytic and non-catalytic processes involving esterification, hydro-genation,
oxidation, acylation, chlorination, fermentation as well as polymerisation. The
process design and development groups has state-of-the-art of pilot plants for
scale ups as well as design tools for preparing basic and detailed engineering
packages, equipment specifications and mechanical design.
|
Patents available for
licensing |
| Title |
Patent No. |
Date of Grant |
- Cultural medium for bamboo shoot sprouting and multiplication and
a method for sprouting and multiplication of bamboo plantlets
|
US 5750401 |
12 May 98 |
- Strain of cephalosporium having ATCC
accession no. 74297, A process of isolating said strain of
cephalosporium and a process for preparing extra-cellular
endoxylanase
|
US 5534429 |
9 July 96 |
- Process for producing alcohol
|
US 5455163 |
3 Oct. 95 |
A strong team of scientists at NCL, having vast experience in
academic as well as industry, is working on several biotechnology-related
projects. The projects are from as diverse fields as agriculture, environment,
and industry. The scientists, in agri division, are working on transgenic crop
plants, micropropagation, production of phytochemicals, biotechnological
investigations for improvement of mango and medicinal plants. They are involved
in the development of eco-friendly bioprocesses like use of enzymes as
alternatives to hazardous chemicals in leather processing, cellulase-free
xylanases in biobleaching of wood pulp, biosorption of heavy metals and
biocontrol of injection in plants. Although the focus is on taking up pilot
projects, the NCL is doing to good work by having tie-ups with universities and
companies.
Market-oriented research
To meet the requirements of the society and industry in
particular, NCL is offering services in the form of technology licensing, doing
contract research, working on collaborative projects, doing consultative and
technical services, and information-based products and services by developing
state-of-the-art technologies for clients in India and abroad. With a mission to
"Linking NCL Research to Market Needs" the laboratory has a Research
Planning and Business Development (RPBD) Group that handles all administrative
matters relating to agreements between NCL and a client.
Even though, it is part of CSIR, it has faced financial
hurdles. In early Nineties, it had taken loans from private financial
institutions and the World Bank to pay for reimbursement of research facilities.
This drove NCL to look at contract research with multinationals as a business
opportunity. These lessons helped the laboratory to negotiate with the
companies, which have immense legal clout far superior to what a lab like NCL
possesses, to generate more than 18 percent of its total budget. Over the years,
it has improved its credibility and aggressively pursued the patents as a goal
and this has helped the organization in earning the respect among customers. NCL
has learnt to negotiate and license IPR’s to the companies outside India.
NCL plans to look at such technologies, which are highly proprietary and are
difficult to source. This, it wants to create an inventory of such technologies
and explore its relevance to India. Besides NCL looks at materials whose
transportation costs are higher. Indian manufacturers of such products are
effectively insulated from the threat of competition by imports. At the dawn of
new century, NCL looks to the future with renewed optimism. Its vision is to
ensure the supremacy of the laboratory in emerging areas of chemical and
biotechnology related fields and to perform research, which is intellectually
challenging and globally competitive. To fulfil its mission to use chemical and
related sciences to produce useful materials and substances efficiently thereby
creating value to the customers in particular and society in general, NCL
believes that its research must be related to the real world and go beyond mere
intellectual stimulation.
Narayan Kulkarni
|
Biotechnology
research activity
The division of biochemical
sciences comprises of 30 scientists and 20 Ph.D students. Scientists are
specialized in biochemistry, microbiology and molecular biology. Besides
the inhouse funding, the research is also supported through external
grants from Government funding agencies such as DST and DBT, New Delhi;
industries and international organizations. Besides carrying out high
quality basic research, major emphasis has been to exploit the research
findings for developing, products and processes of commercial importance.
The three main areas where the ongoing research finds potential
applications include environment, agriculture and health related issues.
MICROBIAL TECHNOLOGY
Development of eco-friendly
technologies using enzymes
Leather industry: NCL, in
collaboration with CLRI, Chennai, has developed a fungal alkaline protease
which has shown promising results when evaluated for soaking, dehairing
and bating in commercial tanneries. NCL is one of the participating
institutes in a New Millennium Indian Technological Leadership Initiative
Coordinated Program devoted to the development of cleaner biotechnological
leather processing.
Textile industry: Application of
cellulases in textile industries for denim washing is relatively a recent
area of research interest. NCL has identified an alkalothermophilic
actinomycete culture producing an alkali stable cellulose. Evaluation of
this cellulose in textile industry conducted in collaboration with
Ahmedabad Textile Industry Research Association (ATIRA) has demonstrated
that the performance of the enzyme was comparable with the commercial
enzymes but the enzyme was superior to them in the property of being able
to function under non-buffering conditions which is a desirable feature
for its commercial application.
Paper and pulp industry: Use of
cellulose-free xylanases for biobleaching of pulp is expected to prevent
environmental pollution caused by the paper industry. NCL has identified
several extremophilic microorganisms, which produce xylanases that are
useful in enhancing the brightness of the pulp in par with chlorine
bleaching exploiting the vast microbial biodiversity.
Aspartic Protease Inhibitor
for HIV
NCL has isolated the first
biologically derived molecule that inhibits HIV-1 protease, the enzyme
involved in the multiplication of the AIDS-causing virus (HIV). The NCL
team has demonstrated that an Aspartic Protease Inhibitor (ATBI) is+olated
from a bacterium the alkalothermophilic Bacillus sp. That thrives in
adverse environments shows inhibition against recombinant HIV-1 protease.
NCL inhibitor has an amino acid sequence that shows no similarity to
existing inhibitors and represents an exciting new class of inhibitors
with important implications for AID therapy. The US and Indian patents
have been granted for the process of preparation of aspartic protease
inhibitor.
Cysteine protease Inhibitors
against malaria
Malaria is one of the most
prevalent infectious diseases of mankind. Its control is becoming
increasingly difficult due to the increasing incidence of strains
resistant to currently used drugs. A program on screening of microbes for
isolation of antimalarial compounds sponsored by a pharmaceutical company
has resulted in the isolation of a few potent cysteine protease inhibitors
which exhibit a significant growth inhibitory activity against Plasmodium
falciparum in a biological assay based on the inhibition of trophozoite
formation.
|
Page(s) 1 |